^
    1m
    Exact Sciences to present late-breaking data from ASCEND-2 study validating its investigational multi-cancer early detection test at AACR Annual Meeting 2024 (Exact Sciences Press Release)
    "Exact Sciences Corp...will present late-breaking data from the first analysis of the ASCEND-2 study demonstrating the compelling performance of its investigational multi-biomarker class, multi-cancer early detection (MCED) blood test...data will be presented at the American Association for Cancer Research® (AACR) Annual Meeting 2024, April 5-10 in San Diego, California."
    Clinical data
    |
    Cancerguard™
    7ms
    Exact Sciences advances early cancer detection and precision oncology programs with data presentations at ESMO 2023 annual congress (Exact Sciences Press Release)
    "Exact Sciences Corp...announced it will present new data supporting the company's research in early cancer detection, genomic testing, and treatment guidance at the 2023 European Society for Medical Oncology (ESMO) Congress, October 20-24, in Madrid, Spain."
    Clinical data
    |
    Cancerguard™ • OncoExTra™ test